Evidence map›Paper›PMID 26697419›Full record

ReviewFrontiers in public health2015

Cord Blood Cells for Developmental Toxicology and Environmental Health.

Dora Il'yasova, Noreen Kloc, Alexander Kinev

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Multifunctional Heterometallic IrChemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  3. Article
  4. Article
  5. Bridging the Data Gap FromFrontiers in public health · 2018
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dora Il'yasovaDivision of Epidemiology and Biostatistics, School of Public Health, Georgia State University , Atlanta, GA , USA.
Noreen KlocDivision of Epidemiology and Biostatistics, School of Public Health, Georgia State University , Atlanta, GA , USA.
Alexander KinevCreative Scientist, Inc. , Durham, NC , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Tox21 program initiated a shift in toxicology toward in vitro testing with a focus on the biological mechanisms responsible for toxicological response. We discuss the applications of these initiatives to developmental toxicology. Specifically, we briefly review current approaches that are widely used in developmental toxicology to demonstrate the gap in relevance to human populations. An important aspect of human relevance is the wide variability of cellular responses to toxicants. We discuss how this gap can be addressed by using cells isolated from umbilical cord blood, an entirely non-invasive source of fetal/newborn cells. Extension of toxicological testing to collections of human fetal/newborn cells would be useful for better understanding the effect of toxicants on fetal development in human populations. By presenting this perspective, we aim to initiate a discussion about the use of cord blood donor-specific cells to capture the variability of cellular toxicological responses during this vulnerable stage of human development.

Indexed as

cord blood cellsdevelopmental toxicityendothelial colony-forming cellsendothelial progenitor cellshigh-throughput testingindividual variabilityin vitro modelsrisk assessment

Identifiers

PMID26697419
PMCPMC4668287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.